| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |